• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用多伦多SPV进行主动脉瓣置换术:长期临床和血流动力学结果。

Aortic valve replacement with the Toronto SPV: long-term clinical and hemodynamic results.

作者信息

Dellgren Göran, Feindel Christopher M, Bos Joanne, Ivanov Joan, David Tirone E

机构信息

Division of Cardiovascular Surgery, The Toronto General Hospital, 200 Elizabeth Street, EN 14-222, Toronto, Ontario, Canada M5N 2C4.

出版信息

Eur J Cardiothorac Surg. 2002 Apr;21(4):698-702. doi: 10.1016/s1010-7940(02)00029-5.

DOI:10.1016/s1010-7940(02)00029-5
PMID:11932170
Abstract

OBJECTIVE

Long-term durability and hemodynamics of stentless valves are unknown. Therefore, this study was undertaken to evaluate long-term clinical and echocardiographic outcome after aortic valve replacement with the Toronto stentless porcine valve (SPV) bioprosthesis at our institution.

METHODS

Between 1991 and 1998, the Toronto SPV was implanted in 255 patients (mean age, 63+/-11 years, range 22-83 years, 181 males and 74 females). Preoperative diagnoses were aortic stenosis (76%), aortic insufficiency (12%) and mixed lesion (12%). New York Heart Association class III and IV were present in 49% (126/255) of the patients preoperatively. Mean valve size implanted was 26.5+/-2.1mm and in addition 34% (86/255) of the patients had coronary artery bypass surgery.

RESULTS

Early mortality was 0.8% (2/255). Actuarial survival at 7 years was 90+/-3%. At 7 years, the freedom from cardiac death was 98+/-2%; from valve-related death, 99+/-1%; from valve reoperation, 97+/-2%; from structural valve degeneration, 97+/-2%; from thromboembolism, 95+/-2%; and from endocarditis, 99+/-1%. At 7 years of follow-up, the transvalvular peak and mean pressure differences across the aortic valve measured with Doppler echocardiography was 9.6+/-5.1 and 3.6+/-2.0 mmHg, respectively.

CONCLUSIONS

The Toronto SPV has provided excellent clinical and hemodynamic results up until 7 years of follow-up.

摘要

目的

无支架瓣膜的长期耐用性和血流动力学尚不清楚。因此,本研究旨在评估在我们机构使用多伦多无支架猪瓣膜(SPV)生物假体进行主动脉瓣置换术后的长期临床和超声心动图结果。

方法

1991年至1998年间,255例患者(平均年龄63±11岁,范围22 - 83岁,男性181例,女性74例)植入了多伦多SPV。术前诊断为主动脉瓣狭窄(76%)、主动脉瓣关闭不全(12%)和混合病变(12%)。术前49%(126/255)的患者为纽约心脏协会III级和IV级。植入瓣膜的平均尺寸为26.5±2.1mm,此外34%(86/255)的患者进行了冠状动脉搭桥手术。

结果

早期死亡率为0.8%(2/255)。7年时的精算生存率为90±3%。7年时,无心脏死亡的概率为98±2%;无瓣膜相关死亡的概率为99±1%;无瓣膜再次手术的概率为97±2%;无结构性瓣膜退变的概率为97±2%;无血栓栓塞的概率为95±2%;无感染性心内膜炎的概率为99±1%。在7年的随访中,用多普勒超声心动图测量的主动脉瓣跨瓣峰值和平均压差分别为9.6±5.

相似文献

1
Aortic valve replacement with the Toronto SPV: long-term clinical and hemodynamic results.采用多伦多SPV进行主动脉瓣置换术:长期临床和血流动力学结果。
Eur J Cardiothorac Surg. 2002 Apr;21(4):698-702. doi: 10.1016/s1010-7940(02)00029-5.
2
Eleven years' experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate.使用Biocor无支架主动脉生物假体的11年经验:临床和血流动力学随访以及长期相对生存率
Eur J Cardiothorac Surg. 2002 Dec;22(6):912-21. doi: 10.1016/s1010-7940(02)00584-5.
3
Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve.使用圣犹达多伦多无支架猪瓣膜进行主动脉瓣置换的长期结果。
Ann Thorac Surg. 2004 Dec;78(6):2076-83; discussion 2076-83. doi: 10.1016/j.athoracsur.2004.05.061.
4
Hemodynamic and clinical outcomes with the Biocor valve in the aortic position: an 8-year experience.主动脉位置植入Biocor瓣膜的血流动力学及临床结果:8年经验
J Thorac Cardiovasc Surg. 2004 Jun;127(6):1616-23. doi: 10.1016/j.jtcvs.2003.10.041.
5
Aortic valve replacement with the Toronto SPV bioprosthesis.使用多伦多SPV生物瓣膜进行主动脉瓣置换术。
J Heart Valve Dis. 1992 Nov;1(2):244-8.
6
Aortic valve replacement with stentless and stented porcine valves: a case-match study.
J Thorac Cardiovasc Surg. 1998 Aug;116(2):236-41. doi: 10.1016/s0022-5223(98)70122-9.
7
Long-Term Outcome of the Sorin Freedom SOLO Stentless Aortic Valve.索林自由SOLO无支架主动脉瓣的长期结果
J Heart Valve Dis. 2016 Nov;25(6):679-684.
8
Long-term results with the Biocor-SJM stentless porcine aortic bioprosthesis.Biocor-SJM无支架猪主动脉生物假体的长期效果。
J Heart Valve Dis. 2002 Jan;11(1):47-53.
9
The Sorin freedom stentless pericardial valve: clinical and echocardiographic performance at 10 years.索林无支架心包瓣膜:10年临床及超声心动图表现
Int J Artif Organs. 2012 Jul;35(7):481-8. doi: 10.5301/ijao.5000103.
10
Experience with stentless aortic xenografts.无支架主动脉异种移植物的经验。
J Heart Valve Dis. 2000 Nov;9(6):794-800.

引用本文的文献

1
Commentary: Can in vitro valve testing reliably predict clinical outcomes?
JTCVS Open. 2022 Feb 11;9:57-58. doi: 10.1016/j.xjon.2022.02.004. eCollection 2022 Mar.
2
Surgical technique of double valve replacement in a patient with osteogenesis imperfecta.成骨不全患者双瓣膜置换术的手术技术
Gen Thorac Cardiovasc Surg. 2016 Apr;64(4):220-3. doi: 10.1007/s11748-014-0433-7. Epub 2014 Jun 11.